Icon

RECORLEV (nda214133)- (150MG)

LEVOKETOCONAZOLE STRONGBRIDGE
150MG
No No
2040-Mar-02 Expired
None None
None No
RECORLEV is a cortisol synthesis inhibitor indicated for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an option or has not been curative.
0 0 0
Total Other Developers 3
Drugs with Suitability No
150MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.